Engineered skin bacteria induce antitumor T cell responses against melanoma
Science · 14.04.2023 · 380 (6641) · 203-210
DOI: 10.1126/science.abp9563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 14.04.2023. Verfasst von Y Erin Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Melanoma, Skin, Staphylococcus epidermidis, Antigens, Neoplasm. Die Arbeit wurde bisher 202-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Certain bacterial colonists induce a highly specific T cell response. A hallmark of this encounter is that adaptive immunity develops preemptively, in the absence of an infection. However, the functional properties of colonist-induced T cells are not well defined, limiting our ability to understand anticommensal immunity and harness it therapeutically. We addressed both challenges by engineering the skin bacterium Staphylococcus epidermidis to express tumor antigens anchored to secreted or cell-surface proteins. Upon colonization, engineered S. epidermidis elicits tumor-specific T cells that circulate, infiltrate local and metastatic lesions, and exert cytotoxic activity. Thus, the immune response to a skin colonist can promote cellular immunity at a distal site and can be redirected against a target of therapeutic interest by expressing a target-derived antigen in a commensal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
- Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.
- ChEM-H Institute, Stanford University, Stanford, CA 94305, USA.
- Dermatology Service, San Francisco Veterans Administration Health Care System, San Francisco, CA 94121, USA.
- Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892, USA.
ORCID-Profile: Y Erin Chen, Djenet Bousbaine, Alessandra Veinbachs, Katayoon Atabakhsh, Alex Dimas, Victor K Yu, Aishan Zhao, Nora J Enright, Kazuki Nagashima, Yasmine Belkaid, Michael A Fischbach
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- Intramural NIH HHS
Zitieren
APA
Chen, Y. E., Bousbaine, D., Veinbachs, A., Atabakhsh, K., Dimas, A., Yu, V. K., Zhao, A., Enright, N. J., Nagashima, K., Belkaid, Y., & Fischbach, M. A. (2023). Engineered skin bacteria induce antitumor T cell responses against melanoma. Science, 380(6641), 203-210. https://doi.org/10.1126/science.abp9563
Vancouver
Chen YE, Bousbaine D, Veinbachs A, Atabakhsh K, Dimas A, Yu VK, et al. Engineered skin bacteria induce antitumor T cell responses against melanoma. Science. 2023;380(6641):203-210. doi:10.1126/science.abp9563
BibTeX
@article{Chen2023,
author = {Chen, Y Erin and Bousbaine, Djenet and Veinbachs, Alessandra and Atabakhsh, Katayoon and Dimas, Alex and Yu, Victor K and Zhao, Aishan and Enright, Nora J and Nagashima, Kazuki and Belkaid, Yasmine and Fischbach, Michael A},
title = {Engineered skin bacteria induce antitumor T cell responses against melanoma},
journal = {Science},
year = {2023},
volume = {380},
number = {6641},
pages = {203--210},
doi = {10.1126/science.abp9563}
}
EUVIMED